Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
The current short term market moving event is the judicial decision in Liquidia’s patent infringement case with United Therapeutics (UTHR) involving PH-ILD. We should receive...
— Steven Kiel
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on United Therapeutics Corp.
No other institutional pitches found for this ticker yet.
More institutional theses from Arquitos Capital Management
Liquidia was the fund's largest contributor in 2025. The fund holds...
The company recently reported excellent full-year results for 2025, showing significant growth in assets under management and revenue. Its adjusted EBITDA...
Finch is executing a strategic Chapter 11 filing to shed lease liabilities and execute a full sale of its assets, including valuable patents and major ongoing litigation claims. The manager believes...